pharmacy semaglutide Flex-Dose 1 mL Injectable 2.5 mg/mL maryland compounding pharmacy semaglutide Weight

The investigators identified 64,000+ adults aged 45 or older with overweight or obesity and atherosclerotic cardiovascular disease (prior heart attack, stroke, or peripheral artery disease) but no diabetes diagnosis, who initiated semaglutide or tirzepatide between May 2022 and January 2025

Recent advances in diagnosis, treatment and follow-up

Blood work may show positive changes in glucose levels and other markers

Thats why researchers are looking at how GLP-1 drugs medications commonly used for weight loss and diabetes may help manage MS

Is Tirzepatide More Effective Than Semaglutide

Treatment Options for GLP-1 Related Hair Loss When hair loss occurs despite preventative measures, several evidence-based treatment options can help manage the condition and support hair regrowth